Delivery Order SPE2DB20D3303-SPE2DB24FA0FT
Award Date
6/21/24
Potential Completion Date
7/15/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,835.01 firm fixed price delivery order is for the supply of 4564118881 - LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,220.76, is a delivery order for the drug LONSURF 20 MG-8.19 MG TABLET 20S. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price instrument. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication LONSURF 20 MG-8.19 MG TABLET 40S. The contract has a firm fixed price of $6,760.14 and an ultimate completion date of July 8, 2025. The contract is not set-aside and was awarded on June 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,166.42 fixed-price delivery order is for the supply of LONSURF 20 MG-8.19 MG tablet, a prescription medication, to support military healthcare programs. The award is part of a $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $16,850.90 firm-fixed-price delivery order is for the supply of the prescription medication LONSURF 20 MG-8.19 MG TABLET 60S, with a performance period through May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of a pharmaceutical product, ORSERDU 345 MG TABLET 30S, to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award, valued at $13,463.77, is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a potential value of up to $999,999,999.00 through December 2025. The IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $8,459.74 from the Defense Logistics Agency (DLA) Troop Support Medical for the provision of pharmaceutical products and medical supplies. The award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order valued at $4,842.18 from the Defense Logistics Agency (DLA) Troop Support Medical. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously awarded solely to Amerisourcebergen Drug Corp by DLA. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...